These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

714 related items for PubMed ID: 12140558

  • 1. Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.
    Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, Dollar J, Nishino I, Kelley RI, Somer H, Straub V, Mathews KD, Moore SA, Campbell KP.
    Nature; 2002 Jul 25; 418(6896):417-22. PubMed ID: 12140558
    [Abstract] [Full Text] [Related]

  • 2. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy.
    Moore SA, Saito F, Chen J, Michele DE, Henry MD, Messing A, Cohn RD, Ross-Barta SE, Westra S, Williamson RA, Hoshi T, Campbell KP.
    Nature; 2002 Jul 25; 418(6896):422-5. PubMed ID: 12140559
    [Abstract] [Full Text] [Related]

  • 3. Glycosylation defects: a new mechanism for muscular dystrophy?
    Grewal PK, Hewitt JE.
    Hum Mol Genet; 2003 Oct 15; 12 Spec No 2():R259-64. PubMed ID: 12925572
    [Abstract] [Full Text] [Related]

  • 4. Defective glycosylation in muscular dystrophy.
    Muntoni F, Brockington M, Blake DJ, Torelli S, Brown SC.
    Lancet; 2002 Nov 02; 360(9343):1419-21. PubMed ID: 12424008
    [Abstract] [Full Text] [Related]

  • 5. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C, Brockington M, Torelli S, Jimenez-Mallebrera C, Kennedy C, Khalil N, Feng L, Saran RK, Voit T, Merlini L, Sewry CA, Brown SC, Muntoni F.
    Hum Mol Genet; 2003 Nov 01; 12(21):2853-61. PubMed ID: 12966029
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Expression and localization of fukutin, POMGnT1, and POMT1 in the central nervous system: consideration for functions of fukutin.
    Yamamoto T, Kato Y, Kawaguchi M, Shibata N, Kobayashi M.
    Med Electron Microsc; 2004 Dec 01; 37(4):200-7. PubMed ID: 15614444
    [Abstract] [Full Text] [Related]

  • 10. Protein glycosylation in disease: new insights into the congenital muscular dystrophies.
    Martin-Rendon E, Blake DJ.
    Trends Pharmacol Sci; 2003 Apr 01; 24(4):178-83. PubMed ID: 12707004
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular recognition by LARGE is essential for expression of functional dystroglycan.
    Kanagawa M, Saito F, Kunz S, Yoshida-Moriguchi T, Barresi R, Kobayashi YM, Muschler J, Dumanski JP, Michele DE, Oldstone MB, Campbell KP.
    Cell; 2004 Jun 25; 117(7):953-64. PubMed ID: 15210115
    [Abstract] [Full Text] [Related]

  • 14. Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of alpha-dystroglycan.
    Xiong H, Kobayashi K, Tachikawa M, Manya H, Takeda S, Chiyonobu T, Fujikake N, Wang F, Nishimoto A, Morris GE, Nagai Y, Kanagawa M, Endo T, Toda T.
    Biochem Biophys Res Commun; 2006 Dec 01; 350(4):935-41. PubMed ID: 17034757
    [Abstract] [Full Text] [Related]

  • 15. Full circle to cobbled brain.
    Ross ME.
    Nature; 2002 Jul 25; 418(6896):376-7. PubMed ID: 12140540
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy.
    Toda T, Kobayashi K, Takeda S, Sasaki J, Kurahashi H, Kano H, Tachikawa M, Wang F, Nagai Y, Taniguchi K, Taniguchi M, Sunada Y, Terashima T, Endo T, Matsumura K.
    Congenit Anom (Kyoto); 2003 Jun 25; 43(2):97-104. PubMed ID: 12893968
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Aberrant neuromuscular junctions and delayed terminal muscle fiber maturation in alpha-dystroglycanopathies.
    Taniguchi M, Kurahashi H, Noguchi S, Fukudome T, Okinaga T, Tsukahara T, Tajima Y, Ozono K, Nishino I, Nonaka I, Toda T.
    Hum Mol Genet; 2006 Apr 15; 15(8):1279-89. PubMed ID: 16531417
    [Abstract] [Full Text] [Related]

  • 20. Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations.
    Huizing M, Rakocevic G, Sparks SE, Mamali I, Shatunov A, Goldfarb L, Krasnewich D, Gahl WA, Dalakas MC.
    Mol Genet Metab; 2004 Mar 15; 81(3):196-202. PubMed ID: 14972325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.